Biote Q2 FY26 net loss widens to $7.4 million; revenue drops 9.5% to $44.2 million
Reuters2026/08/05 20:35- Biote posted a GAAP net loss of $7.4 million, or $(0.23) a share, versus net income of $3.9 million, or $0.10, a year earlier.
- Revenue fell 9.5% to $44.2 million, with procedure revenue down 13.9% to $30.3 million on recall impacts.
- Gross margin narrowed 6.2 percentage points to 65.4%, reflecting higher replacement-product costs and reduced manufacturing efficiencies tied to the recall.
- Non-GAAP adjusted EBITDA slid to $5.6 million from $15.2 million, cutting margin to 12.6% from 31.1%.
- Full-year guidance was revised to revenue above $175 million, adjusted EBITDA above $25 million, with sequential procedure-revenue improvement expected in Q3 and Q4.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
10-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
